Related Experiment Video
Updated: Jun 25, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Risk of Type 1 Diabetes Mellitus in SARS-CoV-2 Patients
Shweta Chahal1, Rojin G Raj1, Ranjeet Kumar1
1Department of Pharmacy Practice, ISF College of Pharmacy, Moga, Punjab, 142001, India.
People with type 1 diabetes mellitus (T1DM) face increased COVID-19 risks due to impaired immunity and heightened inflammation. Vaccination is crucial for this vulnerable population to mitigate severe outcomes and mortality from the virus.
Area of Science:
- Immunology
- Endocrinology
- Infectious Diseases
Background:
- Type 1 diabetes mellitus (T1DM) is associated with increased morbidity and mortality from COVID-19.
- T1DM may compromise both innate and adaptive immune responses.
- Chronic inflammation and oxidative stress are implicated in severe COVID-19 outcomes.
Purpose of the Study:
- To elucidate the mechanisms linking T1DM to severe COVID-19.
- To highlight the role of immune dysregulation and metabolic factors in COVID-19 severity for T1DM patients.
Main Methods:
- Review of existing literature on T1DM, immune function, and COVID-19.
- Analysis of cytokine profiles and oxidative stress markers in T1DM.
- Examination of endothelial function and coagulation status in T1DM.
Main Results:
- Elevated pro-inflammatory cytokines (e.g., TNF-α, IL-1, IL-6) are observed in T1DM patients.
- Severe glucose excursions in T1DM exacerbate oxidative stress via AGEs and PKC.
- Endothelial dysfunction and hypercoagulation in T1DM may contribute to organ failure and ARDS.
Conclusions:
- T1DM patients exhibit a pro-inflammatory and pro-oxidative state, increasing COVID-19 vulnerability.
- Metabolic dysregulation in T1DM significantly contributes to COVID-19 severity.
- Understanding these links underscores the importance of T1DM management and vaccination for COVID-19 prevention.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Psychoneuroimmunology: Diabetes and Cancer

